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A B S T R A C T
Purpose: Despite signiﬁcant advances in our understanding of the biological bases of addictions, these
disorders continue to represent a huge public health burden that is associated with substantial personal
suffering. Efforts to target addictions require consideration of how the improved biological understanding of
addictions may lead to improved prevention, treatment, and policy initiatives.
Method: In this article, we provide a narrative review of current biological models for addictions with a goal
of placing existing data and theories within a translational and developmental framework targeting the
advancement of prevention, treatment, and policy strategies.
Results: Data regarding individual differences, intermediary phenotypes, and main and interactive inﬂu-
ences of genetic and environmental contributions in the setting of developmental trajectories that may be
inﬂuenced by addictive drugs or behavior indicate complex underpinnings of addictions.
Conclusions: Consideration and further elucidation of the biological etiologies of addictions hold signiﬁcant

















Open access under CC BY-NC-ND license.Over the past several decades, substantial research has inves-
igated the biological factors leading to and resulting from addic-
ions [1,2]. The ﬁndings emanating from this work are vitally
mportant if we are to continue to make inroads against addic-
ions, particularly with respect to improving prevention and
reatment strategies [3]. Despite signiﬁcant efforts, excessive
atterns of alcohol, tobacco, and other drug use have been esti-
ated to cost the United States alone$400 billion annually [4].
orldwide, addictions are prevalent, and low- and middle-
ncome countries may not have the resources to adequately ad-
ress these disorders [5,6]. The impact of addictions typically is
idespread, with some estimates indicating seven people being
ffected for each identiﬁed addicted individual, and there often
xist substantial social consequences [7]. Addictions may inﬂu-
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Open access under CC BY-Nnce employers and families, and the impact may be felt trans-
enerationally as parents with addictions may neglect children
r model unhealthy behaviors [8]. Certain developmental
roups, particularly adolescents and young adults, may be par-
icularly vulnerable to developing addictions, as speciﬁc brain
egions, speciﬁcally those involved in exerting behavioral con-
rol, typically mature less rapidly than do brain regions involved
npromotingmotivatedbehaviors like substanceuse [9,10]. Con-
istent with this notion, adolescents and young adults as com-
ared with children and older adults have high rates of addic-
ions [11]. As biological studies identify speciﬁc brain pathways
nd chemicals that may underlie speciﬁc aspects of addictions
nd addiction vulnerability [12], the knowledge gained holds
igniﬁcant potential to advance prevention, treatment, and pol-
cy interventions.
oundaries of Addiction
Before embarking on a discussion of the biological factors
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“addiction.” Historically, there has been variation in the applica-
tion of the word. “Addiction” is derived from the Latin verb
addiceremeaning “bound to” or “enslaved by,” and in its original
usage was not associated with substance use behaviors [13].
Dating back several hundred years, the term became linked to
excessive patterns of alcohol use and later to excessive patterns
of drug use such that by the 1980s, therewas apparent consensus
among some groups of experts that addiction could be deﬁned as
“compulsive drug use” [14]. However, over the past 15 years or
so, there has been a debate as to whether excessive participation
in nondrug behaviors like gambling, eating, sex, shopping, Inter-
net use, and video gaming, to name several, might be considered
addictions [15–17]. All of these domains appear to hold rele-
vance to adolescents, as rates of problem and pathological gam-
bling have been estimated to be two- to fourfold higher in ado-
lescents than adults; problematic gambling, shopping, and
Internet use have each been associatedwith adversemeasures of
health and functioning in adolescents; and obesity rates have
risen dramatically in youth over the past several decades [17–
22]. In addition, these behaviors may follow developmental fre-
quencies similar to substance use behaviors, with high rates of
use and addiction in adolescence and early adulthood and lower
rates in older adulthood [11,23]. Among adolescents, it also ap-
pears important to consider levels of engagement that fall short
of addiction, as subsyndromal engagement has been associated
with immediate and longer-termadversemeasures of health and
functioning [18,24,25]. The unique characteristics of adolescents
as compared with adults (e.g., more likely to have primary em-
phasis on school as compared with work, more likely to be
inﬂuenced by parental monitoring, less likely to have head-of-
household obligations, less likely to seek treatment for these
behaviors, and less likely to have large sums ofmoney to support
engagement in addictive behaviors) also warrant consideration
and may explain some differences in frequencies (e.g., with re-
spect to compulsive shopping behaviors) in adolescents versus
adults [26,27].
The debate over what behaviors, and the level of engagement
in such behaviors, might be considered as addictions has in-
volved consideration of the core components of addiction
[23,28]. One proposition is that central features of addiction
include continued engagement in a behavior despite adverse
consequences, diminished control over participation in the be-
havior, compulsive participation, and a craving or appetitive
urge state immediately preceding engagement in the behavior
[23,29]. If one adopts these features as the deﬁning aspects of
addiction, then nonsubstance behaviors like gambling might be
considered within an addiction’s framework. Consistent with
this notion, pathological gambling is being proposed for catego-
rization together with substance use disorders in a “Substance
Use and Addictive Disorders” category in the Diagnostic and Sta-
tistical Manual of Mental Disorders-5 [30]. Such a deﬁnition for
addiction and such groupings could substantially increase the
estimated costs of addictions to society. For example, if foods and
food consumption might be considered addictive [31], the costs
to society could increase tremendously given the high preva-
lence estimates of obesity and the associated health costs related
to type 2 diabetes, hypertension, heart disease, and other obesity-
related conditions [32]. The consumption of energy drinks and
other caffeinated beverages may also be considered within an
addiction framework, and this may be particularly relevant to [adolescents given their patterns of consumption of these
drinks [33].
It should be noted that although many of the common sub-
stances of abuse (tobacco, alcohol, and cannabis among themost
common, with a recent increase in prescription medication
abuse in some countries like the United States) show patterns of
initiation and escalation of use during adolescence, food con-
sumption follows a different pattern. That being said, many of
the features thatmight converge tomake adolescents vulnerable
to addiction (maturation and associated hormonal and other
biological changes, greater independence, greater access to ad-
dictive substances/materials, emerging nonaddiction psychopa-
thology) may represent factors associated with altered eating
behaviors and obesity.
Biological Models of Addiction
Multiple biological models have been proposed to under-
stand addictions and addiction vulnerability, and many of these
models are complementary and not mutually exclusive. As an
extensive review of each of these models is beyond the scope of
this article, interested readers are directed to the references cited
for additional aspects of each model. In addition, theories of
addiction as related to current neurobiological understandings
are reviewed in chapters 2–5 of reference [34].
Early reward-centric models focused on pleasurable aspects
of taking drugs and proposed that drugs may “hijack” brain
circuits involved in responses to “natural” rewards like sex or
food [35,36]. A central component in this circuitry is the nucleus
accumbens located in the ventral striatum and receiving dopa-
minergic innervation from the ventral tegmental area (termed
the mesolimbic dopamine system). This nucleus accumbens has
at times been termed the brain’s “reward center,” given that all
known drugs with abuse potential, as well as natural rewards,
lead to dopamine release in this structure [37,38]. However, a
broader range of neurotransmitters (including opioids, cannabi-
noids, serotonin, norepinephrine, acetylcholine, glutamate, and
-aminobutyric acid [39–41]) contributes to addiction, and mo-
ecular entities (receptors, transporters) for sensing these neu-
otransmitters are expressed in speciﬁc brain regions (e.g., Figure
in reference [41]). Recent studies suggest that the functions of
he nucleus accumbens and dopamine function therein aremore
omplex and involve learning (particularly reward based) and
eward anticipation and valuation, salience attribution (i.e., as-
igning degrees of relevance to items, decisions, or behaviors), as
ell as loss processing [1,36]. Consistent with a role for reward-
ng effects of drugs in addictive processes and a role for dopa-
ine in this process, an incentive salience model of drug addic-
ion proposes that “liking” a drug may be separated from
wanting” [42,43]. Another reward-based model suggests a “re-
ard deﬁciency syndrome” inwhich individuals with addictions
eek out and engage in addictive behaviors to compensate for
ypofunctioning reward signals in the mesolimbic dopamine
athway [44]. In contrast to the incentive salience model, the
eward deﬁciency model may be particularly relevant to self-
edication theories of addiction [45,46]. Despite their differ-
nces, these twomodels share some theoretical consistencywith
ther motivational theories like the “IRISA” (impaired response
nhibition and salience attribution) and others detailed later in
he text that describe behavioral and biological differences in
ransitions from initial, sporadic to regular, habitual use of drugs
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mesolimbic dopamine system has been proposed to be particu-
larly relevant to initiation and binge/intoxication, noradrenergic
and stress pathways particularly relevant to withdrawal and
negative affect components, and prefrontal cortical, hippocam-
pal, amygdalar, and insular contributions particularly relevant to
preoccupation and craving (Figure 2 in reference [41]).
Motivation-focused models have proposed that addiction
ight be considered a disorder of misdirected motivation in
hich relatively greater priority is given to drug use and rela-
ively lesser priority is given to other motivated behaviors like
amilial care, work, or school [39,49,50]. In these processes, de-
cisions to pursue typically smaller immediate rewards (e.g., a
drug-related high) are made at the expense of typically larger
delayed rewards (e.g., longer-term life possibilities emanating
from studying for an exam or taking children to school). These
behaviors and choices may be modeled from a biological per-
spective, and speciﬁc brain regions including the ventral stria-
tum and ventromedial prefrontal cortex appear closely linked to
reward processing, risk/reward decision making, and the selec-
tion of smaller immediate rewards, whereas the selection of
larger delayed rewards has been found to involve more dorsal
prefrontal cortical brain regions [51–53]. These ﬁndings suggest
that more developed brain regions involved in higher-order (so-
called executive) processes are important in risk–reward deci-
sion making relevant to addictions [2]. From a developmental
perspective, these prefrontal cortical brain regions are among
the last to mature, and this feature of brain developmentmay, in
part, contribute to adolescent vulnerability to addictions and
other risk behaviors and mental health disorders (Figure 1 in
reference [9]) [50,54,55].
Adolescent Addiction Vulnerability
Other motivation-focused models have proposed arguably
more extensive involvement of brain regions whose functions
may contribute to motivated behaviors, addiction vulnerability,
and addictions. One model focusing on adolescent vulnerability
to addiction separated primary and secondary motivational
neurocircuitry (Figure 1 in reference [50]). The primary circuitry
involves the prefrontal cortex, striatum (including the caudate
and putamen), and thalamus. Parallel loops involving these
structures have been proposed as primary to motivations and
behaviors, including those in addictions [56,57]. The limbic loops
that involvemore ventral regions of the cortex and striatumhave
been proposed to be particularly relevant to novel or impulsive
behaviors, whereas the associative and sensorimotor loops that
involvemore dorsal regions of the cortex and striatumhave been
proposed to be particularly relevant to habitual or compulsive
behaviors [48,58]. Thismodel, as well as others, appears applica-
ble to both substance and nonsubstance addictions, including
behaviors related to excessive food intake andobesity [16,58,59].
A secondary motivational neurocircuitry has been proposed
to explain how other brain circuits may inﬂuence motivational
decision-making processes and behaviors within the primary
circuitry [50]. Speciﬁcally, multiple factors (both external inﬂu-
ences like parental monitoring, peer behavior, and access to
drugs or addictive materials, as well as internal states, all of
which are particularly relevant to adolescents) may inﬂuence
decisions to use drugs or engage in addictive behaviors [60]. Both
internal and external inﬂuences may be relevant to adolescents’
initiation and continued engagement in addictive behaviors. Forexample, one’s emotional state may contribute, and periods of
feeling upset or stressed may lead to drug use [61,62]. As such,
brain regions involved in emotional processing, including the
amygdala and anterior cingulate and medial prefrontal cortices,
may provide important information into primary motivational
circuitry and contribute to decisions to use drugs in emotionally
reactive “hot” states as compared with reﬂective “cold” states
[61–63].
Given the relative immaturity in adolescents of brain regions
like the prefrontal cortex that are involved in emotional and
motivational processing including in the regulation of craving for
drugs and food [64,65], adolescents may be biologically vulner-
able to engagement in addictive behaviors. Consistent with this
notion, adolescents show largely subcortical/limbic responses to
favorite food cues and individualized stress cues [66], whereas
adults show both subcortical/limbic and prefrontal cortical re-
sponses [67,68]. In biological models focusing speciﬁcally on
adolescent addiction vulnerability [50], the function of brain
regions contributing to other states (e.g., relating to hunger,
thirst, or sex drive) relating tomotivational drives and behaviors
has been cited as important. For example, brain regions such as
the hypothalamus and septum that are involved in these homeo-
static processes may contribute importantly [50,69,70].
Personally relevant experiences may also inﬂuence motiva-
tions and decisions to use drugs, and in the setting of relatively
smaller contributions of prefrontal cortically mediated self-
control in adolescence, such experiential recollection may play a
relatively larger role in adolescent decision making related to
addictive behaviors. Brain regions such as the hippocampus or
temporal cortices that have been implicated in storing and re-
calling memories, particularly emotional ones, related to previ-
ous drug use (or other relevant situations) may thus provide
important contextual memory contributions [50,71–73]. Other
brain regions such as the insula (involved in sensing physical or
somatic states) and parietal cortex (involved in attentional pro-
cessing) may also participate by inﬂuencing motivations and
decisions to engage in addictive behaviors [74–76]. Thus, the
emotional volatility of adolescents and its inﬂuence on how
attention is directed may contribute signiﬁcantly to adolescent
participation in substance use and other behaviors with addic-
tive potential, and brain regions involved in emotional process-
ing (e.g., the amygdala) are important contributors [77]. Impor-
tantly, input from brain regions involved in higher-order
executive function (e.g., the dorsolateral prefrontal cortex) may
allow for “top-down” control over motivations, in part driven by
“bottom-up” subcortical processes, to engage in addictive behav-
iors [2,78]. Consistently, prefrontal cortical brain regions like the
inferior frontal gyrus are among those most frequently impli-
cated in studies of impaired impulse control [79], aswell as in the
control of craving or desire [64,65]. Taken together, given their
neurodevelopmental status, adolescents may not be able to reg-
ulate emotional or motivational states to the same degree as
adults.
The extent to which the aforementioned speciﬁc neurobio-
logical or behavioral features reﬂect normal or aberrant develop-
ment is currently incompletely understood, and it appears as
though arguments for both cases could be made. Importantly,
characteristics that are developmentally appropriate (e.g., in-
creased risk taking) are also associatedwith real-lifemeasures of
adverse functioning (including with respect to addictive behav-
iors) [80–82], and it follows that the neurobiological underpin-
nings would show a similar pattern. However, some studies
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related and risk taking-related responses [9,83], whereas other
studies indicate that they show relatively diminished activation
[84,85]. Similarly, some studies indicate that adolescents with
addictions as compared with those without addictions show
relatively diminished ventral striatal activation during reward
anticipation, much like adults with addictions compared with
those without addictions [86–88]. Similar patterns of ventral
striatal activation also appear to apply to risk taking in adoles-
cents and adults with addictions [89,90]. Thus, although adoles-
cents in general may show exaggerated reward- or risk-related
brain activations in reward circuitry, it is possible that thosewho
may be showing relatively blunted activations are most im-
portant to target with respect to addictions. However, other
data suggest that features associated with substance abuse
(e.g., externalizing tendencies) correlate positively with re-
ward anticipation-related activation of the ventral striatum in
adolescence [91]. Some of these differences might reﬂect
study design (e.g., with respect to conﬂating anticipatory
phases of reward processing [92]), differences in samples (e.g.,
with respect to substance use or othermeasures [93]), or other
factors. As described later in the text, understanding the bio-
logical correlates of such individual differences represents a
major area of research in that it might help advance individu-
alized interventions. Despite these gaps in our understanding,
given that some of the normative developmental features of
adolescencemayrepresent risk factors foraddictionandadolescent
engagement isassociatedwithpooreroutcome,navigation through
this developmental epoch in a healthy fashion is important.
HowMight Drug Use or the Addictive Process Inﬂuence
Brain Structure and Function?
Using the aforementioned frameworks to consider the neuro-
circuitry involved in addictions, it is important to consider that
changes may occur over time in the structure and function of
these brain motivational pathways. Some changes may reﬂect
normative developmental processes [54,55,94]; some may re-
ﬂect changes directly related to the addictive process [49,95];
and others may reﬂect changes related to recent or long-term
substance exposure that may or may not be central to addictive
processes [96,97]. Models and studies have begun to examine
these inﬂuences. One model posits that there are “allostatic”
changes (i.e., alterations in baseline set points) thatmay occur on
repeated exposure to drugs or stressors [95,98]. Such exposures
may differentially inﬂuence speciﬁc neural structures, with ini-
tial involvement of the mesolimbic dopamine system progress-
ing to the nucleus accumbens, prefrontal cortex, and extended
amygdalawith continued drug exposure and increasing compul-
sivity (Figure 4 in reference [41]). Such progressive involvement
of brain regions and their function in brain circuits may underlie
a recalibration of baseline set points in the functioning of moti-
vational circuitry that could contribute importantly to repeated
drug taking and complicate attempts to cease engagement in
addictive behaviors. A nonmutually exclusive possibility in-
volves the progressive involvement of more dorsal corticostria-
tothalamocortical circuits as behavior moves from more con-
sciously decision oriented to more habitually driven with
repeated engagement over time (Figure 1 in references [48,58]
and Figures 1, 3, and 11 in reference [57]). How changes related
to normal development (including the aforementioned complex
ones during adolescence) interact with behavioral engagementand substance use thus may involve complex interactions, par-
ticularly when one considers individual differences in genetic
composition and life experiences and their interactive effects
(see later in the text). Such environmental inﬂuences may come
frommultiple domains salient to adolescents, including parents,
peers, school, church, and extracurricular involvement, to list
several, and may include positive prosocial inﬂuences and nega-
tive ones, such as bullying or other forms of abuse.
Predisposing Factors Versus Sequelae of Use
In addiction, disentangling the inﬂuences of long-term and
recent effects of speciﬁc drugs on brain structure and function
can be complicated. That being said, drugs like cocaine appear to
have signiﬁcant inﬂuences on cortical structures, with repeated
exposure progressively involving ventral to lateral to dorsal re-
gions of the prefrontal cortex [96]. Alcohol can also inﬂuence
brain structure and function, and decreased gray matter and
poorer white matter integrity have been found in individuals
with alcoholism [99–102]. Among adolescents, both structural,
volumetric, and white matter changes have been observed in
association with 1–2 years of drinking alcohol, particularly with
respect to binge-pattern drinking [103]. Both gray matter and
white matter integrity are important to brain function, with the
latter particularly relevant to how brain regions connect and
therefore operate in conjunction with one another. Alcohol’s
inﬂuences on gray and white matter structures may explain, in
part, differences seen in performance on cognitive tests in groups
of individuals with different addictions [104,105]. However, lon-
gitudinal studies in people with carefully assessed measures of
drug-taking behaviors will help further clarify to what extent
differences may reﬂect characteristics (e.g., neurobiological fea-
tures related to impulsive tendencies) existing before drug expo-
sure, those relating to drug exposure, those relating more pre-
cisely to changes in the addictive process, or a combination
thereof (possibly evolving in an interactive fashion). On this
framework, it is important to consider developmental changes in
brain structure and function that occur naturally as people age
[9,54,55]. For example, in rats, exposure to alcohol during ado-
lescence increases risky or impulsive decision making in adult-
hood [106]. These ﬁndings suggest that if adolescents consume
alcohol, such consumption may lead to tendencies promoting
alcohol consumption, generating a vicious cycle of addictive be-
havior. However, controlled studies investigating such questions
are lacking in humans. Thus, at this time, it is important to be
cautious about inferring causality, particularly as many human
studies involve associational rather than longitudinal designs.
Consideration of Individual Differences
It is reasonable to consider that certain factors (including
individual differences in genetic composition and/or environ-
mental exposures)may exist, develop, or be experienced early in
life, precede the exposure to addictive substances or engagement
in addictive behaviors, and thus predispose to addiction vulner-
ability or resilience [107]. For example, there exists a genetic
variant coding for an enzyme (acetylaldehyde dehydrogenase)
involved in the metabolism of alcohol. Individuals with the vari-
ant that is associated with slowermetabolism of alcohol and the
accumulation of acetylaldehyde on alcohol consumption
(leading to an unpleasant or aversive response) are protected
against the development of alcoholism. The ways in which
f
a
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of addictions are arguably less clear. However, twin data sug-
gest that 30%–70% of the risk for developing addictions may be
genetic [108], suggesting that an improved understanding of
speciﬁc genetic factors relating to addictions and addiction
vulnerability is relevant [109].
Moreover, environmental factors may interact with genetic
actors, and these are important to consider in the stages of
ddictions [110–112]. That is, individuals with one type of ge-
netic background may respond differently than individuals of
another genetic background to the same environmental stimu-
lus. Such gene-by-environment interactions have been sug-
gested in brain-imaging studies and may have relevance to ad-
dictions and other mental health conditions. For example,
speciﬁc variants of the gene coding for the serotonin transporter
that are associated with different functioning of the transporter
protein are associatedwith differences in amygdala activation to
emotional stimuli [113]. Given ﬁndings linking emotional dys-
regulation to addictive behaviors [114], amygdala function to
motivation and addictions [50,115,116], and serotonin trans-
porter gene variation relating to externalizing tendencies in
youth as a function of socioeconomic status [117], such varia-
tions may, in part, explain how different individuals respond
differently to environments with respect to developing addic-
tions. Furthermore, the timing of exposure to speciﬁc environ-
mental stimuli (e.g., childhood trauma) should be considered
within this framework and within the context of developmental
brain changes [118]. This example is meant to reﬂect one of
multiple possible genes and gene–environment interactions
that may contribute to addictions and other conditions. As many
genes with commonly occurring variations have been proposed
to contribute to aspects of addiction [109,110,119], it will be
important to examine a broad range of genetic and environmen-
tal factors relating to addiction vulnerability and resilience.
Sex/Gender
Other individual differences also warrant consideration. For
example, males as compared with females tend to more fre-
quently encounter problemswith addiction, although the gender
composition varies somewhat according to addictive substance
or behavior and developmental stage. For example, alcohol and
cocaine dependence and pathological gambling are typically
male predominant, whereas compulsive shopping is more typi-
cally identiﬁed in females across the lifespan [120]. However,
some recent U.S. data have found that girls aged 12–17 years
have rates of alcohol and illicit drug abuse or dependence equal
to or greater than those for boys [121,122]. Despite these differ-
ences, some gender-related differences appear relatively consis-
tent across disorders. For example, a telescoping phenomenon,
initially described for alcoholism, later for drug use, and more
recently for gambling, exists whereby, on average, women as
compared with men begin engagement in the behavior later in
life than do men, but the time between initial participation and
development of a problem is shorter (or telescoped) inwomen as
compared with men [123,124]. Differences in motivations for
engaging in addictive behaviors also exist between females and
males, with women more likely to participate to escape from
negative mood states (negative reinforcement) and men more
likely to participate to experience positive feelings (positive re-
inforcement) [125–127]. These differences have important im-
plications. First, they may relate to important differences in co-occurring disorders whereby addictive behaviors like gambling
are more closely linked to depression in girls and women as
comparedwith boys andmen [67,128]. Second, they suggest that
differences exist in biological underpinnings of addictions in
women and men, particularly with respect to responses to neg-
ative (stress/anxiety) and positive (addiction cue) responses.
Consistently, as compared with same-sexed nonaddicted com-
parison subjects, women with cocaine dependence show more
robust patterns of brain activation differences in brain motiva-
tion circuitry in responses to stress cues, and men with cocaine
dependence show more robust patterns of brain activation dif-
ferences in brain motivation circuitry in responses to drug cues
[129]. Third, these ﬁndings have treatment implications, as in-
terventions likemindfulness-based approaches that target stress
reduction might be differentially helpful for women and men
with addictions [130]. The extent towhich gender-related differ-
ences relate to biological sex hormones (e.g., progesterone, es-
trogens, testosterone) and/or environmental factors like gender-
related differences in social acceptability of speciﬁc behaviors
warrants additional investigation, as well as does how these
might best be targeted in interventions [131–134].
Race, Culture, and Ethnicity
Factors related to culture, race, and ethnicity also warrant
consideration in the propensity to develop addictions. Differ-
ences in genetic compositionsmay vary according to race and, in
part, explain differences observed in rates of addictions across
racial and ethnic groups [135,136]. Environmental factors re-
lated to differences in acculturation, cultural expectations, socio-
economics, stress exposure, and other domains also warrant
consideration, as these might differ across cultural groups
[134,137]. Some of these factors (e.g., stress exposure like child-
hood trauma) have been linked both to the propensity to develop
addictions and to brain structure and function, including in re-
gions implicated in reward, motivation, and addictions
[138,139], although the precise natures of these relationships
warrant further investigation in longitudinal studies in people
[140–142]. As such, disentangling the precise contributions to
addictions among different racial/ethnic groups is both an im-
portant and complex undertaking.
Intermediary Phenotypes
One important approach that has been used for the past
decade involves the study of intermediary phenotypes or endo-
phenotypes [143]. This approach considers that multiple factors,
includingmultiple gene variations, likely contribute to psychiat-
ric disorders like addictions, and that these disorders represent
heterogeneous groupings. Intermediary phenotypes or endo-
phenotypes represent constructs that are not readily visible but
represent measurable constructs that may more closely link to
biological factors (and by extension, their prevention and treat-
ment) than do the heterogeneous diagnostic groupings. Endo-
phenotypes also are proposed to be identiﬁable, albeit to a
lesser extent, in unaffected familymembers of people with the
disorder.
An example of an endophenotype that has been proposed for
addictions and some other psychiatric disorders is impulsivity
[2,59,109,144]. Impulsivity has been deﬁned as propensity to-
ward rapid unplanned reactions to internal or external stimuli
































































M.N. Potenza / Journal of Adolescent Health 52 (2013) S22–S32 S27reactions to the impulsive individual or others [144,145]. Animal
studies involving controlled designs indicate that impulsivity
before drug exposure can predict the propensity to develop drug
addictions [2,146,147], and substance exposure (e.g., alcohol ex-
posure during adolescence) can lead to increased impulsivity
[106]. Thus, these animal studies indicate that impulsivity may
predispose to the development of addictions and may increase
after long-term substance exposure, potentially leading towors-
ening addiction. Among people, impulsivitymeasures are higher
not only in stimulant-dependent individuals but also in their
siblings, consistent with the notion that impulsivity represents
an endophenotype for addictions [148]. In addition, these simi-
larities appear to relate to neural regions that have been linked in
previous studies to poor impulse control [149]. Better impulse
control in children as young as 4 years has been associated with
better scholastic functioning during adolescence and differences
in prefrontal cortical and ventral striatal functioning during per-
formance of an impulse control task as adults [150,151].
Although these ﬁndings are encouraging and suggest that
impulsivity may represent a relevant target for treatment devel-
opment in addictions [3,152–154], caution should be noted for
several reasons.
First, impulsivity is a complex construct that can be fraction-
ated, and components related to decisionmaking (choice impul-
sivity) and action (response impulsivity) have been identiﬁed in
multiple studies [155–157]. Thus, facets of impulsivity may rep-
resent separate and dissociable endophenotypic constructs.
Choice and response impulsivity often do not associate, may
involve different neurochemical contributions, and appear to
relate differentially to aspects of addiction [2,154,156,158,159].
For instance, although response impulsivity has been found in
animal models to predict compulsive or addictive drug use
[2,146], choice impulsivity has not and has rather been associ-
ated with resistance to extinction and propensity to relapse
[160]. As such, these aspects of impulsivity may relate speciﬁ-
cally to different aspects of addictive processes (e.g., initiation vs.
persistence).
Similarly, “hot” and “cold” processes that might contribute to
impulsive tendencies and behaviors may have different neural
underpinnings that reﬂect different genetic, environmental, and
interactive components (refer to the aforementioneddescription
and Figure 1 in reference [9] describing subcortical/limbic and
prefrontal cortical contributions to motivated behaviors and
their changes during adolescence). In addition, in this context,
it is important to consider genetic factors that may inﬂuence
adolescent behavior including psychopathic tendencies, risk
taking, and distress tolerance [117,161,162], as well as gene–
environment interactions, such as with respect to brain re-
sponses and psychopathology related to early childhood
trauma [113,163,164]. Such interactions appear to have im-
portant clinical implications with respect to addictive behav-
iors in adolescents; for example, greater stress-induced risk
taking has been linked to poorer treatment outcome in ado-
lescent smokers [165].
Second, self-report and behavioral measures of impulsivity,
venwithin the same domain,may not correlate, suggesting that
owpeople perceive their behavioral tendenciesmay differ from
heir actual behavior [154]. Thus, these measures may relate
ifferentially to speciﬁc aspects of addictions relevant to preven-
ion and treatment efforts [3,154]. Theymay also relate differen-
ially to the interaction between environmental exposures and
ubstance use behaviors. For example, self-reported but not be- [avioral measures of impulsivity have been reported to mediate
he relationships between different forms of stress (trauma, ma-
or and recent life events, and chronic stressors) and alcohol
onsumption [166]. Among adolescents seeking treatment for
ddictive behaviors, real-life behavioral and hypothetical self-
eport measures of discounting at treatment onset have been
ssociated with treatment outcome in tobacco and marijuana
mokers, respectively, indicating that these constructs relate
mportantly to clinically relevant measures and have the poten-
ial to identify subgroups of adolescents warranting particular
ttention [154,167]. Additional therapies (e.g., those like dialec-
ical behavioral therapy or mindfulness-based stress reduction)
ay be helpful for adolescents who show impaired impulse
ontrol during emotionally arousing or stressful states [168,169].
Third, impulsivity, and facets thereof, appears to follow de-
elopmental trajectories that are important to consider [170].
or example, although self-reported impulsivity has been re-
orted to decrease in a linear fashion from adolescence to adult-
ood, sensation-seeking appears to follow a curvilinear pattern,
ncreasing during early adolescence and decreasing thereafter
171]. Individual differences in impulsivity appear important to
ubstance use behavior; for example, during late adolescence/
arly adulthood (age 18–25 years), groups showing the greatest
ecreases in impulsivity demonstrated accelerated decreases in
lcohol involvement [172].
Fourth, impulsivity represents only one of multiple potential
ndophenotypes relevant to addictions. Other constructs (e.g.,
ompulsivity, emotional reactivity, stress responsiveness) repre-
ent other potential endophenotypes thatwarrant consideration
n understanding the biologies of addictions [2,61]. Each of these
ntermediary phenotypes has potential relevance for adolescent
ddiction vulnerability, particularly given the neurobiological
nd behavioral changes during this developmental epoch.
revention, Treatment, and Policy Implications
Amajor goal in advancing our understanding of the biologies
f addictions involves the translation of this knowledge into
mproved prevention, treatment, and policy strategies. Arguably,
hese efforts might be most easily understood for treatment
evelopment, particularly with respect to pharmacological ther-
pies (Figure 1 in reference [3]). That is, an improved under-
tanding of the neurobiological underpinnings of addictions, for
xample, with respect to the function of speciﬁc neurotransmit-
ers in speciﬁc brain regions, might help to develop medications
or the speciﬁc receptors or transporters they target. In some
ays, efforts in this area have fallen short. Speciﬁcally, despite
he ﬁndings that mesolimbic dopamine release in the nucleus
ccumbens is considered a central component of drug addic-
ions, medications that block dopamine receptors in this brain
egion have shown limited efﬁcacy in the treatment of addic-
ions, and in nonsubstance addictions like pathological gambling
ave been associated with progambling motivations and behav-
ors [3,173]. However, drugs that may inﬂuence mesolimbic do-
amine function indirectly, such as opioid receptor antagonists
ike naltrexone and nalmefene and glutamatergic compounds
ike N-acetyl cysteine, have shown more consistent ﬁndings in
oth substance and nonsubstance addictions like pathological
ambling [16,174,175]. Other molecular targets that may inﬂu-
ncemesolimbic dopamine function, like the serotonin 1B recep-
or, show similarities in substance and nonsubstance addictions
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teins like the serotonin transporter targeted by serotonin re-
uptake inhibitors, a class of compounds that has shown only
modest effects in treating addictions [16,175]. Given the biolog-
ical links between substance addictions and obesity (e.g., with
respect to striatal dopamine function), some of these targetsmay
extend to excessive eating behaviors [16]. Given the involvement
of cannabinoids in both eating behaviors and substance use dis-
orders [16,178], medication development targeting cannabinoid
unction also warrants consideration across addictive behaviors.
he cross-addiction targeting of cannabinoids would ﬁt with
heir roles in ventral striatal functioning and stress system re-
ponsiveness, as well as the clinical population of adolescent
annabis users who tend to use multiple substances. It is also
mportant to consider heterogeneitieswith respect to patterns of
xcessive food consumption, and that some patterns (e.g., those
elated to binge-eating disorder or “food addiction”) might help
dentify important subgroups with respect to underlying biolo-
ies and effective prevention and treatment strategies [179].
Intermediary phenotypes or endophenotypes also warrant
onsideration as treatment targets, and preliminary ﬁndings
ith impulsivity appear encouraging [152,153]. Speciﬁc groups
of individuals (e.g., adolescents who demonstrate greater choice
impulsivity as demonstrated by steeper discounting) may re-
spond preferentially to different interventions like contingency
management [167,180]. In addition, medications and behavioral
reatments that target cognitive enhancementmayhelp improve
ecision making and behavioral control in addictions, and these
ay operate by inﬂuencing the brain circuits underlying impulse
ontrol [3,181,182].
Itwill be important to consider neurodevelopmental changes,
articularly with respect to adolescence and adolescent addic-
ion vulnerability, and how this may impact adult functioning,
nd howdifferences inmaturational rates of cortical and subcor-
ical regions may inﬂuence both addiction and other mental
ealth vulnerabilities and the mechanisms of actions (and effec-
iveness) of speciﬁc therapies [9,10,50,183,184]. For example,
he use of instructions derived from cognitive behavioral thera-
ies for addictions in adult tobacco smokers has been shown to
ncrease connectivity between prefrontal cortical regions impli-
ated in behavioral control and subcortical regions implicated in
ravings [64]. The extent towhich these strategiesmightwork in
dolescents who may as a group show less prefrontal cortical
aturity and ability to harness such cortical control may offer
oth challenges and opportunities. However, preliminary data
ndicate that adolescents demonstrate beneﬁt from cognitive
ehavioral therapies (e.g., with respect to smoking cessation).
imilarly, the efﬁcacy and tolerability ofmedications in the treat-
ent of youth warrant consideration, for example, potential
isks associated with widely used medications like serotonin
euptake inhibitors or stimulants. Speciﬁc medications effective
n adults need to be evaluated separately in youth for efﬁcacy and
olerability, with both short-term and long-term outcomes in
ind. Individual differences (e.g., with respect to past trauma
xposure) also warrant consideration [185].
Multiple interventions for adolescents have received empiri-
al support. The prevention strategies with the most empirical
upport involve targeting important risk factors and bolstering
mportant protective factors at individual, familial, and commu-
ity levels [186]. Multiple behavioral approaches, including con-
ingencymanagement, motivational interviewing, and cognitive
ehavioral and family therapies, have empirical support, with harying levels of data to support each approach in speciﬁc pop-
lations [180,187,188]. Comparatively, few medications have
een tested for their efﬁcacy and tolerability among adoles-
ents with substance abuse or dependence [189], and even
ess research has examined the extent to which pharmaco-
herapies might be helpful among nonsubstance addictions
190]. As in adults, other considerations (e.g., co-occurring
isorders and aftercare) are important in the treatment of
dolescent addictions [191,192].
Other potential targets exist. For example, poor white mat-
er integrity has been found to contribute to both substance
nd nonsubstance addictions like pathological gambling, as
ell as to obesity [105,193–196]. The extent to which phar-
acological and behavioral mechanisms might alter white
atter integrity to improve treatment outcome warrants con-
ideration [3,197–199].
Biological knowledge of addictionsmayhelp informadvances
n policy and prevention [200]. An improved understanding of
enetic factors or related endophenotypes might help identify
ndividuals with vulnerability factors that could be targeted pre-
entively for interventions. Similarly, an improved understand-
ng of gene–environment interactions, and how speciﬁc envi-
onmental exposuresmay inﬂuence gene expression (epigenetic
henomena), may also improve prevention strategies. Identiﬁ-
ation of brain-imaging measures that reliably link to addictions
ould aid in both prevention and treatment strategies. Such pre-
ention and treatment interventions would be most effective
ith policies and related resources that facilitate their enact-
ent, and this may be particularly difﬁcult in countries that
evote limited resources to mental health interventions [5,201].
Other considerations relevant to prevention, treatment, and
olicy, such as the potential inﬂuences of low socioeconomic
tatus, may also be informed by biological advances. For exam-
le, early life adversity has been linked to altered brain structure
nd function [138,139]. In addition, individuals lower in social
tatus show hypofunctioning striatal systems, and this may in-
uence reward- and motivation-related behaviors including ad-
iction propensity [202]. The extent to which this impact oper-
tes at a communal or national level warrants consideration.
Importantly, policy may be informed across addictive behav-
ors in a manner that beneﬁts from effective interventions in
ther domains. For example, effective tax strategies that have
elped curtail tobacco use, particularly among adolescents and
oung adults, may be used to model similar efforts with respect
o food taxation [31,203]. It may also be that certain foods (e.g.,
ighly caloric, “hyperpalatable” processed foods) may possess
reater addictive potential than do other foods and thus may
arrant increased attention from public health and policy per-
pectives [31].With respect to adolescents, limiting fast food and
ugared sodas (e.g., in school cafeterias and vending machines)
arrants consideration. Similarly, policy efforts could restrict
he availability of substances with addictive potential thatmight
ead to greater adolescent initiation or use (“bidis” or ﬂavored
igarettes and alcohol-containing caffeinated beverages). Using
nformation related to individual differences in biologies may
elp to optimize such policies, and the resulting policies may
ave substantial impact on reducing the societal burdens of
ddictions. From a global perspective, having resources and pol-
cies that would help increase the currently scarcemental health
nd addiction efforts in low- andmiddle-income countries could
ave a major impact on world health [204–206].
M.N. Potenza / Journal of Adolescent Health 52 (2013) S22–S32 S29Conclusions
The growing body of data on the neurobiology of addiction
has the potential to address more effectively one of the major
public health problems facing societies today. A neurodevelop-
mental perspective with a focus on youth vulnerability could
help advance efforts related to early interventions.
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